Vision Centers for Eye Care
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if establishing vision centers in South Asia can enhance access to eye care and improve eye health. It will assess whether these centers increase eye care visits, the ownership and use of glasses, and overall vision improvement. Communities will receive a vision center either immediately or at a later time, and results will be compared. Ideal candidates for the trial live in rural areas lacking nearby primary eye care services and are located within 20-100 km of a base hospital. As an unphased trial, this study provides a unique opportunity to contribute to better eye care access in underserved communities.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that the establishment of a vision center is safe for improving eye care access and outcomes?
A previous study did not specifically examine safety data for setting up vision centers. However, the main service offered is basic eye care, which generally poses low risk. No specific problems were reported during the establishment of these centers. The goal is to make eye care more accessible, and similar services have shown that safety issues are rare. Trained technicians provide eye care, usually involving routine, non-invasive procedures.
Overall, setting up a vision center focuses on improving access to eye care rather than introducing a new medical treatment. Therefore, safety risks are minimal and primarily related to the general operation of a community health service.12345Why are researchers excited about this trial?
Researchers are excited about the establishment of vision centers for eye care because these centers bring accessible, basic eye care services directly to communities, which is not always possible with traditional hospital-based care. Unlike standard options that often require traveling to specialized facilities, these centers will have trained vision technicians on-site to provide immediate care and necessary referrals. This approach aims to reduce the gap in eye care access and improve early detection and treatment of vision problems.
What evidence suggests that the establishment of a vision center is effective for improving eye care access and outcomes?
This trial will compare the immediate establishment of a vision center with a delayed establishment. Studies have shown that setting up vision centers improves access to eye care and enhances eye health. Research indicates that these centers increase visits to eye care facilities, ensuring people receive necessary eye exams. This often results in more individuals obtaining and wearing glasses, which can enhance their vision. Evidence also suggests that when communities have easy access to these services, their visual acuity improves. Overall, vision centers play a crucial role in promoting better eye health and making eye care more accessible.13467
Who Is on the Research Team?
Kieran O'Brien, PhD, MPH
Principal Investigator
University of California, San Francisco
Are You a Good Fit for This Trial?
This trial is for communities in South Asia to assess if establishing vision centers affects eye care access and eye health. It's not specific to individuals but rather involves entire communities that are chosen randomly.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Population-based surveys conducted to assess baseline eye health and access to eye care
Intervention
Establishment of vision centers in intervention communities to provide basic eye care services
Follow-up
Population-based surveys and hospital record reviews to assess outcomes after intervention
What Are the Treatments Tested in This Trial?
Interventions
- Establishment of a vision center
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor
Seva Foundation
Collaborator
Proctor Foundation
Collaborator